Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitis

Stopped Company decision; No safety or efficacy concerns (see detailed description)

Conditions

• Nonalcoholic Steatohapatitis

Interventions

• DRUG: Roflumilast
• DRUG: Pioglitazone
• DRUG: Placebo
• DRUG: Placebo

Sponsor

AstraZeneca